Overview
Ke-hong Bi practices practicing medicine in China.
Their clinical expertise encompasses Chronic Myelomonocytic Leukemia (CMML), Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), and Leukemia.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ke-hong Bi
Is Ke-hong Bi a top-rated expert for Chronic Myelomonocytic Leukemia (CMML)?
MediFind is an objective health platform that identifies experts based on real-world data. Ke-hong Bi is classified as an Experienced expert for Chronic Myelomonocytic Leukemia (CMML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ke-hong Bi participate in research or clinical trials?
Yes. Ke-hong Bi has published 8 articles and abstracts on conditions like Chronic Myelomonocytic Leukemia (CMML). You can view a list of Ke-hong Bi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Myelomonocytic Leukemia (CMML)
- Graft Versus Host Disease (GvHD)
- LeukemiaBi isExperienced. Learn about Leukemia.